Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

nutrition · Mechanism Report

Is low serum vitamin B12 with elevated methylmalonic acid a characteristic pattern of true tissue B12 deficiency?

Low serum vitamin B12 together with elevated methylmalonic acid indicates true intracellular, tissue-level vitamin B12 deficiency.

SupportedJune 19, 20269 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Low serum vitamin B12 with elevated methylmalonic acid is a characteristic pattern of true tissue vitamin B12 deficiency.

laying out figure…
0 of 1 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim states that low circulating B12 plus raised MMA is the classic biochemical signature of cellular cobalamin depletion. Mechanistically, tissue B12 shortage impairs methylmalonyl-CoA mutase activity, causing accumulation and release of MMA, so an elevated MMA provides functional confirmation of intracellular deficiency. Interpretation should account for factors that raise MMA independently, such as reduced renal clearance.

Verified conclusion

Low serum vitamin B12 coupled with elevated methylmalonic acid (MMA) is the classic biochemical footprint of true intracellular, tissue-level vitamin B12 deficiency. In clinical practice, relying solely on total serum B12 can be misleading due to low diagnostic sensitivity and specificity. Evaluating functional biomarkers is essential for an accurate diagnosis, especially in older adults.

Clinical and effectiveness evidence

  • Diagnostic synergy: While low serum B12 (typically defined as <200 pg/mL or 148 pmol/L) suggests depletion, up to 30% of patients with clinically significant tissue deficiency present with borderline or normal serum levels.
  • Functional validation: Measuring MMA acts as a highly sensitive secondary assessment. An elevated serum MMA level (typically >0.27 µmol/L) in the presence of low or borderline-low serum B12 confirms metabolic depletion at the cellular level, offering a diagnostic sensitivity exceeding 95% for true tissue deficiency.

Mechanistic explanations

  • Cofactor deficiency: Within mitochondria, adenosylcobalamin (AdoCbl)—an active form of vitamin B12—serves as the obligate cofactor for the enzyme methylmalonyl-CoA mutase (MMUT).
  • Enzymatic block: When tissue cobalamin is depleted, MMUT activity is severely compromised. This prevents the normal conversion of L-methylmalonyl-CoA to succinyl-CoA in the propionate catabolic pathway.
  • Metabolite accumulation: This metabolic block leads to an intracellular accumulation of methylmalonyl-CoA, which is subsequently hydrolyzed and released into the bloodstream as MMA, serving as a direct biochemical readout of intracellular deficiency.

Limitations and clinical considerations

  • Renal function: Because MMA is cleared by the kidneys, renal insufficiency or chronic kidney disease (frequent in patients over 65) can elevate serum MMA levels independently of vitamin B12 status. In such cases, methylmalonic acid must be interpreted alongside renal markers (such as eGFR) or paired with homocysteine.

Bottom line

The combination of low serum vitamin B12 and elevated methylmalonic acid represents a highly characteristic, biochemically validated pattern of true tissue-level vitamin B12 deficiency. It directly reflects both a depletion of circulating vitamin pools and a functional intracellular metabolic block.

References

  1. Biomarkers and Algorithms for the Diagnosis of Vitamin B12 Deficiency — pmc.ncbi.nlm.nih.gov ↗
  2. The application and interpretation of laboratory biomarkers for the evaluation of vitamin B12 status — pmc.ncbi.nlm.nih.gov ↗
  3. Vitamin B12 status in health and disease: a critical review. Diagnosis of deficiency and insufficiency – clinical and laboratory pitfalls — tandfonline.com ↗
  4. Causes and early diagnosis of vitamin B12 deficiency. — pmc.ncbi.nlm.nih.gov ↗
  5. Human B12-dependent enzymes: Methionine synthase and Methylmalonyl-CoA mutase. — pmc.ncbi.nlm.nih.gov ↗
  6. Role of vitamin B12 on methylmalonyl-CoA mutase activity — pmc.ncbi.nlm.nih.gov ↗
  7. Relationship between Vitamin B12 and Cobalt Metabolism in Domestic Ruminant: An Update — mdpi.com ↗
  8. Effects of vitamin B12-deficiency on testes tissue in rats. — jstage.jst.go.jp ↗
  9. Methylmalonyl acidemia: from mitochondrial metabolism to defective mitophagy and disease — tandfonline.com ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible11 sourcesAre zearalenone and fumonisins common Fusarium contaminants in cereal grains?→Plausible11 sourcesCan low alkaline phosphatase and altered red-cell indices signal nutritional deficiency?→